Call Now Open
2026 Oxford-Harrington Rare Disease Scholar Award
January 15, 2026
The Oxford-Harrington Rare Disease Centre (OHC), a partnership between the University of Oxford, UK and Harrington Discovery Institute at University Hospitals, Cleveland, Ohio, is seeking highly innovative projects for its 2026 Rare Disease Scholar Award, which accelerates promising therapeutics discoveries from academic labs...
Continue Reading
January 24, 2023
A team led by investigators at Massachusetts General Hospital (MGH), including Marc Wein, MD, PhD, Massachusetts General Hospital, 2018 Harrington Scholar-Innovator, might lead to a new, more convenient drug for preventing and treating osteoporosis. Continue Reading
January 12, 2023
Dr. Christiane Wrann of Massachusetts General Hospital selected for research aimed at using the novel exercise hormone irisin to treat Alzheimer’s disease Continue Reading
November 22, 2022
Travis Dunckley, PhD, University of Arizona, 2016 ADDF-Harrington Scholar and team have developed a candidate drug they hope may successfully block the development or advancement of Alzheimer’s disease in Down syndrome patients. Continue Reading
November 17, 2022
Study led by University Hospitals and Case Western Reserve University team details a small-molecule drug that lowers cholesterol by 70% in animal models Continue Reading
October 19, 2022
PIC Therapeutics has closed a $35 million Series A financing round centered around the advancement of its lead asset, a novel therapeutic for advanced metastatic breast cancer. Continue Reading
October 19, 2022
Grant award provides MD/PhD candidates with funding and expertise to translate promising scientific discoveries into medicines Continue Reading
August 18, 2022
Harrington Scholar developing a universal treatment to prevent and treat influenza A. Continue Reading
August 15, 2022
Licensing IP for SIK Inhibitors to Radius Health Continue Reading
August 09, 2022
Development of an exercise wearable to help personalize exercise and minimize the risks of dementia. Continue Reading
August 08, 2022
Hope to Help Patients with Retinitis Pigmentosa Continue Reading